Total Payments
$409.48
2024 Payments
$49.27
Companies
17
Transactions
21
Medicare Patients
2,102
Medicare Billing
$221,319
Payment Breakdown by Category
Food & Beverage$409.48 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $409.48 | 21 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $68.19 | 3 | $0 (2023) |
| Covidien LP | $53.66 | 1 | $0 (2019) |
| Novo Nordisk Inc | $37.55 | 2 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $30.29 | 2 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $29.50 | 1 | $0 (2022) |
| Phathom Pharmaceuticals, Inc. | $18.25 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $18.13 | 1 | $0 (2022) |
| ITI, Inc. | $17.86 | 1 | $0 (2022) |
| ABBVIE INC. | $17.51 | 1 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.18 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $49.27 | 3 | Phathom Pharmaceuticals, Inc. ($18.25) |
| 2023 | $80.28 | 4 | Otsuka America Pharmaceutical, Inc. ($45.59) |
| 2022 | $152.08 | 8 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($30.29) |
| 2021 | $45.29 | 3 | Novo Nordisk Inc ($16.36) |
| 2020 | $15.25 | 1 | Amarin Pharma Inc. ($15.25) |
| 2019 | $67.31 | 2 | Covidien LP ($53.66) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/18/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 01/05/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Diabetes | ||||||
| 12/15/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: NEUROSCIENCE | ||||||
| 07/21/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: PSYCHIATRY | ||||||
| 02/24/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: NEUROSCIENCE | ||||||
| 01/03/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $29.50 | General |
| Category: Rare Disease | ||||||
| 10/12/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Gastroenterology | ||||||
| 09/20/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/09/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Obesity | ||||||
| 07/25/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: PSYCHIATRY | ||||||
| 07/06/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: PSYCHIATRY | ||||||
| 05/27/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: Central Nervous System | ||||||
| 03/17/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Gastroenterology | ||||||
| 12/01/2021 | Almatica Pharma LLC | LOREEV XR (Drug), SERTRALINE HCL | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: ANTI-ANXIETY | ||||||
| 08/16/2021 | Neurocrine Biosciences, Inc. | ONGENTYS (Drug), INGREZZA | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: NEUROLOGY | ||||||
| 03/18/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Obesity | ||||||
| 08/31/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Cardiovascular | ||||||
| 11/22/2019 | Penumbra, Inc. | Indigo (Device) | Food and Beverage | Cash or cash equivalent | $13.65 | General |
| Category: Peripheral Intervention | ||||||
| 01/07/2019 | Covidien LP | — | Food and Beverage | In-kind items and services | $53.66 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 502 | 559 | $231,009 | $46,386 |
| 2022 | 7 | 505 | 598 | $323,912 | $50,875 |
| 2021 | 8 | 695 | 837 | $439,911 | $81,712 |
| 2020 | 6 | 400 | 460 | $183,176 | $42,347 |
Total Patients
2,102
Total Services
2,454
Medicare Billing
$221,319
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 149 | 166 | $61,138 | $14,184 | 23.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 122 | 159 | $41,637 | $9,400 | 22.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 41 | 42 | $33,096 | $7,529 | 22.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $26,594 | $6,181 | 23.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 71 | 72 | $31,178 | $4,469 | 14.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 52 | 53 | $32,913 | $3,922 | 11.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 12 | 12 | $4,453 | $701.14 | 15.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 164 | 244 | $55,388 | $15,464 | 27.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 102 | 108 | $35,532 | $9,580 | 27.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 72 | 72 | $35,784 | $8,590 | 24.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 60 | 63 | $81,283 | $7,015 | 8.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 75 | 76 | $85,928 | $5,309 | 6.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 16 | 17 | $23,103 | $3,225 | 14.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 16 | 18 | $6,894 | $1,692 | 24.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 222 | 344 | $77,946 | $23,585 | 30.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 128 | 142 | $46,629 | $12,794 | 27.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 93 | 93 | $46,117 | $10,202 | 22.1% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 77 | 79 | $90,539 | $9,340 | 10.3% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Office | 2021 | 26 | 26 | $33,826 | $8,520 | 25.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2021 | 26 | 26 | $29,640 | $5,577 | 18.8% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 79 | 82 | $74,968 | $5,226 | 7.0% |
| 45384 | Removal of tissue abnormalities, tumors, or polyps of large bowel by hot biopsy forceps, using a flexible endoscope | Facility | 2021 | 15 | 16 | $20,228 | $2,960 | 14.6% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 17 | 17 | $15,422 | $2,320 | 15.0% |
| 11104 | Punch biopsy of single skin lesion | Office | 2021 | 12 | 12 | $4,596 | $1,187 | 25.8% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 53 | 58 | $38,738 | $8,985 | 23.2% |
About Dr. Stuart Goldstein, DO
Dr. Stuart Goldstein, DO is a Surgery healthcare provider based in Pulaski, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1326032178.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Goldstein, DO has received a total of $409.48 in payments from pharmaceutical and medical device companies, with $49.27 received in 2024. These payments were reported across 21 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($409.48).
As a Medicare-enrolled provider, Goldstein has provided services to 2,102 Medicare beneficiaries, totaling 2,454 services with total Medicare billing of $221,319. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Surgery
- Location Pulaski, VA
- Active Since 09/08/2005
- Last Updated 07/22/2020
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1326032178
Products in Payments
- REXULTI (Drug) $68.19
- Saxenda (Drug) $37.55
- XIFAXAN (Drug) $30.29
- ULTOMIRIS (Biological) $29.50
- VOQUEZNA (Drug) $18.25
- XARELTO (Drug) $18.13
- CAPLYTA (Drug) $17.86
- VRAYLAR (Drug) $17.51
- TRINTELLIX (Drug) $17.18
- JARDIANCE (Drug) $16.07
- Vascepa (Drug) $15.25
- NEXLETOL (Drug) $14.95
- ONGENTYS (Drug) $14.48
- LOREEV XR (Drug) $14.45
- Indigo (Device) $13.65
- AUSTEDO (Drug) $12.51
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in Pulaski
Eric Steen, Do, DO
Surgery — Payments: $12,684
Surgery $12,684
Dr. Courtney Mckeown, M.d, M.D
Surgery — Payments: $1,727
Surgery $1,727
Dr. Yung Chan, M.d, M.D
Surgery — Payments: $652.17
Surgery $652.17
Dr. Kenna Williams, M.d, M.D
Surgery — Payments: $188.60
Surgery $188.60
Dr. Todd Lucas, Md, MD
Surgery
Surgery
James Lathrop, Md, MD
Surgery
Surgery